180 WEALTH ADVISORS, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1730817 FEDERAL WAY, WA

Position in CRSP

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$395,796

+$42,399 QoQ

Shares Held

7,257

-2.3% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#10

of 48 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 65.495383767397.ToString("F0")% Shared 0.ToString("F0")% None 34.504616232603006.ToString("F0")%

Healthcare · as of Jun 30, 2026

180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. CRSP ranks #5 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MNKD	Mannkind Corp	4,959,351	$21,126,835
2	MRNA	Moderna, Inc.	35,750	$2,503,572
3	INCY	Incyte Corp	7,045	$798,621
4	RXRX	Recursion Pharmaceuticals, Inc.	190,562	$699,362
5	CRSP	CRISPR Therapeutics AG This page	7,257	$395,796
6	VKTX	Viking Therapeutics, Inc.	8,753	$341,454
7	VRTX	Vertex Pharmaceuticals Inc / Ma	548	$272,208
8	EXEL	Exelixis, Inc.	4,266	$232,113

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$395,796	7,257	-2.3%	Shares	Sole	2026-07-07
2026-03-31	$353,397	7,429	+1.4%	Shares	Sole	2026-05-01
2025-12-31	$384,227	7,327	+5.5%	Shares	Sole	2026-01-09
2025-09-30	$450,105	6,945	-5.4%	Shares	Sole	2025-10-16
2025-06-30	$357,260	7,345	+15.7%	Shares	Sole	2025-07-31
2025-03-31	$216,056	6,349	+22.9%	Shares	Sole	2025-04-09
2024-12-31	$203,373	5,167	+18.4%	Shares	Sole	2025-01-14
2024-09-30	$205,020	4,364	+17.9%	Shares	Sole	2024-11-01
2024-06-30	$199,891	3,701	+20.4%	Shares	Sole	2024-07-16
2022-09-30	$200,820	3,073	—	Shares	Sole	2022-10-12
No filing history on record for this holder in this stock.